Physician profile
Albert J Chang
NPI 1790984805
$2,183.29
in general payments reported to CMS, 2019-2025
8 companies · $369 in 2025
The $369 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $886 · 2021: $182 · 2023: $747 · 2025: $369.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $666 · Travel and Lodging: $450.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $666.01 |
| Travel and Lodging | $449.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $885.87 | 2019 | |
| Stryker Corporation | $622.99 | 2023 | Everest Spinal System |
| Blue Earth Diagnostics | $143.75 | 2025 | Posluma |
| Astellas Pharma US INC | $125.98 | 2021 | |
| Cook Medical LLC | $123.98 | 2023 | Saeed |
| Genzyme Corporation | $122.31 | 2025 | |
| Alcresta Therapeutics, INC. | $102.72 | 2025 | Relizorb |
| Takeda Pharmaceuticals U.S.A., INC. | $55.69 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Albert Chang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.